Please upgrade your browser

We built this website using the latest browser technologies to deliver the very best experience.

This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.

We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.

Download ChromeDownload Microsoft Edge
Sensyne Health | AIM Delist

Shareholder information

AIM Delisting

On 18 April 2022, Sensyne Health plc (the “Company” or “Sensyne”) announced the Company's intention to cancel the admission of its Ordinary Shares to trading on AIM (the "AIM Delisting"), subject to shareholder approval.

The announcement can be found here.

The shareholder circular can be found here.

The final day of trading of the Company’s Ordinary Shares on AIM was 17 June 2022 with the AIM Delisting taking effect at 8.00 a.m. on 20 June 2022.

Post the de-listing from AIM, Ordinary Shares will continue to be a valid equity interest in the Company with full voting rights, rights to future dividends, etc., as currently enjoyed by holders of Ordinary Shares. However, following the AIM Delisting there will be no public market in the United Kingdom on which the Ordinary Shares can be traded.